| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,651 | 19,891 | 21,551 | 26,971 | | Cost of Revenue | 17,027 | 18,790 | 20,720 | 23,693 | | | Gross Profit | 1,623 | 1,101 | 831 | 3,278 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,420 | 2,676 | 2,954 | 3,105 | | Non Recurring | 353 | 645 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,149) | (2,220) | (2,123) | 173 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (78) | (53) | 10 | 76 | | Earnings Before Interest And Taxes | (1,227) | (2,274) | (2,113) | 249 | | Interest Expense | 150 | 140 | 95 | 162 | | Income Before Tax | (1,377) | (2,414) | (2,208) | 87 | | Income Tax Expense | (523) | (867) | (919) | 10 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (854) | (1,547) | (1,289) | 77 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (854) | (1,547) | (1,289) | 77 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($854) | ($1,547) | ($1,289) | $77 |
|
0.51% Nasdaq 
Income Statement
